Table 1.
Characteristics of the Study Population
| Trans women aged < 50 years | Trans women aged ≥ 50 years | Trans men | |
|---|---|---|---|
| No. of people | 1089 | 934 | 1,036 |
| Age (years) in 2015 | 38 (9) | 60 (8) | 40 (14) |
| Age (years) at start HT | 26 (22–33) | 40 (31–48) | 25 (21–33) |
| Duration HT (years) | 8 (3–16) | 19 (11–29) | 9 (2–22) |
| BMI (kg/m2) (n = 2756) | 23.9 (4.2) | 25.7 (4.6) | 25.8 (4.9) |
| Smoking, % yes (n = 2614) | 44.7 | 49.0 | 47.8 |
| Gonadectomy, % yes | 57.8 | 80.9 | 69.8 |
| T‐score lumbar spine | −1.13 (1.23) | −0.91 (1.33) | −0.18 (1.19) |
| T‐score total hip | −0.77 (0.85) | −0.67 (0.88) | +0.04 (0.98) |
| T‐score femoral neck | −0.99 (0.94) | −1.19 (0.88) | −0.30 (1.05) |
| Laboratory | |||
| Estradiol (pmol/L) | 211 (132–308) | 241 (138–391) | 147 (102–205) |
| Testosterone (nmol/L) | 1.2 (0.7–1.4) | 1.3 (1.0–1.3) | 25.0 (17.1–36.5) |
| LH (IU/L) | 2.2 (0.2–9.7) | 3.2 (0.3–8.4) | 3.6 (0.9–11.5) |
HT = hormonal treatment; BMI = body mass index; LH = luteinizing hormone. Characteristics are shown as mean with standard deviation, median with interquartile range, or percentage. Associations are shown as odds ratios (OR) with 95% confidence intervals (CI).
Laboratory measurements were available for 66% of the trans women and 72% of the trans men.